ANIXA BIOSCIENCES, INC. Net Income (Loss) Attributable to Noncontrolling Interest
ANIXA BIOSCIENCES, INC. (ANIX) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$19.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-07-31 was -$19.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-04-30 was -$20.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-01-31 was -$20.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-10-31 was -$27.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$101.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$144.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$119.00K.
- ANIXA BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$176.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$19.00K 10-Q · filed 2026-09-09 | -$39.00K derived: sum of 2 quarters · filed 2026-09-09 | -$59.00K 10-Q · filed 2026-09-09 | -$86.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-04-30 | -$20.00K 10-Q · filed 2026-06-10 | -$40.00K 10-Q · filed 2026-06-10 | -$67.00K derived: sum of 3 quarters · filed 2026-06-10 | -$89.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-01-31 | -$20.00K 10-Q · filed 2026-03-09 | -$47.00K derived: sum of 2 quarters · filed 2026-03-09 | -$69.00K derived: sum of 3 quarters · filed 2026-09-09 | -$92.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-10-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -$49.00K derived: sum of 2 quarters · filed 2026-09-09 | -$72.00K derived: sum of 3 quarters · filed 2026-09-09 | -$101.00K 10-K · filed 2026-01-12 | ||||
| 2025-07-31 | -$22.00K 10-Q · filed 2026-09-09 | -$45.00K derived: sum of 2 quarters · filed 2026-09-09 | -$74.00K 10-Q · filed 2026-09-09 | -$104.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-04-30 | -$23.00K 10-Q · filed 2026-06-10 | -$52.00K 10-Q · filed 2026-06-10 | -$82.00K derived: sum of 3 quarters · filed 2026-06-10 | -$120.00K derived: sum of 4 quarters · filed 2026-06-10 | ||||
| 2025-01-31 | -$29.00K 10-Q · filed 2026-03-09 | -$59.00K derived: sum of 2 quarters · filed 2026-03-09 | -$97.00K derived: sum of 3 quarters · filed 2026-03-09 | -$138.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-10-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -$68.00K derived: sum of 2 quarters · filed 2026-01-12 | -$109.00K derived: sum of 3 quarters · filed 2026-01-12 | -$144.00K 10-K · filed 2026-01-12 | ||||
| 2024-07-31 | -$38.00K 10-Q · filed 2025-09-10 | -$79.00K derived: sum of 2 quarters · filed 2025-09-10 | -$114.00K 10-Q · filed 2025-09-10 | -$145.00K derived: sum of 4 quarters · filed 2025-09-10 | ||||
| 2024-04-30 | -$41.00K 10-Q · filed 2025-05-28 | -$76.00K 10-Q · filed 2025-05-28 | -$107.00K derived: sum of 3 quarters · filed 2025-05-28 | -$144.00K derived: sum of 4 quarters · filed 2025-05-28 | ||||
| 2024-01-31 | -$35.00K 10-Q · filed 2025-03-11 | -$66.00K derived: sum of 2 quarters · filed 2025-03-11 | -$103.00K derived: sum of 3 quarters · filed 2025-03-11 | -$122.00K derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-10-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | -$68.00K derived: sum of 2 quarters · filed 2025-01-10 | -$87.00K derived: sum of 3 quarters · filed 2025-01-10 | -$119.00K 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | -$37.00K 10-Q · filed 2024-09-06 | -$56.00K derived: sum of 2 quarters · filed 2024-09-06 | -$88.00K 10-Q · filed 2024-09-06 | -$141.00K derived: sum of 4 quarters · filed 2024-09-06 | ||||
| 2023-04-30 | -$19.00K 10-Q · filed 2024-06-04 | -$51.00K 10-Q · filed 2024-06-04 | -$104.00K derived: sum of 3 quarters · filed 2024-06-04 | -$133.00K derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2023-01-31 | -$32.00K 10-Q · filed 2024-03-12 | -$85.00K derived: sum of 2 quarters · filed 2024-03-12 | -$114.00K derived: sum of 3 quarters · filed 2024-03-12 | -$158.00K derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-10-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | -$82.00K derived: sum of 2 quarters · filed 2024-01-16 | -$126.00K derived: sum of 3 quarters · filed 2024-01-16 | -$176.00K 10-K · filed 2024-01-16 | ||||
| 2022-07-31 | -$29.00K 10-Q · filed 2023-09-06 | -$73.00K derived: sum of 2 quarters · filed 2023-09-06 | -$123.00K 10-Q · filed 2023-09-06 | -$181.00K derived: sum of 4 quarters · filed 2023-09-06 | ||||
| 2022-04-30 | -$44.00K 10-Q · filed 2023-06-14 | -$94.00K 10-Q · filed 2023-06-14 | -$152.00K derived: sum of 3 quarters · filed 2023-06-14 | -$206.00K derived: sum of 4 quarters · filed 2023-06-14 | ||||
| 2022-01-31 | -$50.00K 10-Q · filed 2023-03-17 | -$108.00K derived: sum of 2 quarters · filed 2023-03-17 | -$162.00K derived: sum of 3 quarters · filed 2023-03-17 | -$200.00K derived: sum of 4 quarters · filed 2023-03-17 | ||||
| 2021-10-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | -$112.00K derived: sum of 2 quarters · filed 2023-01-04 | -$150.00K derived: sum of 3 quarters · filed 2023-01-04 | -$174.00K 10-K · filed 2023-01-04 | -$173.52K 10-K · filed 2022-01-04 | |||
| 2021-07-31 | -$54.00K 10-Q · filed 2022-09-09 | -$53.62K 10-Q · filed 2021-09-01 | -$92.00K derived: sum of 2 quarters · filed 2022-09-09 | -$116.00K 10-Q · filed 2022-09-09 | -$115.75K 10-Q · filed 2021-09-01 | -$132.98K derived: sum of 4 quarters · filed 2022-09-09 | ||
| 2021-04-30 | -$38.00K 10-Q · filed 2022-06-10 | -$38.04K 10-Q · filed 2021-06-10 | -$62.00K 10-Q · filed 2022-06-10 | -$62.12K 10-Q · filed 2021-06-10 | -$78.98K derived: sum of 3 quarters · filed 2022-06-10 | -$94.08K derived: sum of 4 quarters · filed 2022-06-10 | ||
| 2021-01-31 | -$24.00K 10-Q · filed 2022-03-11 | -$24.09K 10-Q · filed 2021-03-11 | -$40.98K derived: sum of 2 quarters · filed 2022-03-11 | -$56.08K derived: sum of 3 quarters · filed 2022-03-11 | -$73.98K derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-10-31 | -$16.98K derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | -$32.08K derived: sum of 2 quarters · filed 2022-01-04 | -$49.98K derived: sum of 3 quarters · filed 2022-01-04 | -$74.01K 10-K · filed 2022-01-04 | ||||
| 2020-07-31 | -$15.10K 10-Q · filed 2021-09-01 | -$33.00K derived: sum of 2 quarters · filed 2021-09-01 | -$57.03K 10-Q · filed 2021-09-01 | -$80.60K derived: sum of 4 quarters · filed 2021-09-01 | ||||
| 2020-04-30 | -$17.90K 10-Q · filed 2021-06-10 | -$41.93K 10-Q · filed 2021-06-10 | -$65.50K derived: sum of 3 quarters · filed 2021-06-10 | -$91.52K derived: sum of 4 quarters · filed 2021-06-10 | ||||
| 2020-01-31 | -$24.03K 10-Q · filed 2021-03-11 | -$47.60K derived: sum of 2 quarters · filed 2021-03-11 | -$73.62K derived: sum of 3 quarters · filed 2021-03-11 | -$110.86K derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-10-31 | -$23.57K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | -$49.59K derived: sum of 2 quarters · filed 2021-01-07 | -$86.83K derived: sum of 3 quarters · filed 2021-01-07 | -$171.60K 10-K · filed 2021-01-07 | ||||
| 2019-07-31 | -$26.02K 10-Q · filed 2020-09-08 | -$63.26K derived: sum of 2 quarters · filed 2020-09-08 | -$148.03K 10-Q · filed 2020-09-08 | -$237.06K derived: sum of 4 quarters · filed 2020-09-08 | ||||
| 2019-04-30 | -$37.24K 10-Q · filed 2020-06-09 | -$122.01K 10-Q · filed 2020-06-09 | -$211.04K derived: sum of 3 quarters · filed 2020-06-09 | -$327.69K derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-01-31 | -$84.77K 10-Q · filed 2020-03-09 | -$173.79K derived: sum of 2 quarters · filed 2020-03-09 | -$290.44K derived: sum of 3 quarters · filed 2020-03-09 | -$304.43K derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-10-31 | -$89.03K derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | -$205.68K derived: sum of 2 quarters · filed 2020-01-09 | -$219.66K derived: sum of 3 quarters · filed 2020-01-09 | -$247.06K 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | -$116.65K 10-Q · filed 2019-09-06 | -$130.63K derived: sum of 2 quarters · filed 2019-09-06 | -$158.03K 10-Q · filed 2019-09-06 | |||||
| 2018-04-30 | -$13.98K 10-Q · filed 2019-06-12 | -$41.38K 10-Q · filed 2019-06-12 | ||||||
| 2018-01-31 | -$27.40K 10-Q · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |